By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company CSL Limited

CSL Limited (CSLLY)

OTC Currency in USD
$67.35
+$0.04
+0.06%
Last Update: 3 Sept 2025, 19:58
$130.40B
Market Cap
5.59
P/E Ratio (TTM)
2.41%
Forward Dividend Yield
$65.13 - $107.05
52 Week Range

CSLLY Stock Price Chart

Explore CSL Limited interactive price chart. Choose custom timeframes to analyze CSLLY price movements and trends.

CSLLY Company Profile

Discover essential business fundamentals and corporate details for CSL Limited (CSLLY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

29 Dec 2009

Employees

32.70K

CEO

Paul F. McKenzie

Description

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

CSLLY Financial Timeline

Browse a chronological timeline of CSL Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 8 Feb 2026

Upcoming earnings on 30 Oct 2025

Dividend declared on 21 Aug 2025

A dividend of $0.81 per share was announced, adjusted to $0.81. The dividend will be paid on 10 Oct 2025.

Earnings released on 18 Aug 2025

Earnings released on 18 Aug 2025

Earnings released on 11 Feb 2025

EPS came in at $2.56 , while revenue for the quarter reached $5.08B .

Dividend declared on 11 Feb 2025

A dividend of $0.60 per share was announced, adjusted to $0.60.

Earnings released on 30 Oct 2024

EPS came in at $2.03 , while revenue for the quarter reached $4.16B .

Dividend declared on 10 Sept 2024

A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 9 Oct 2024.

Earnings released on 13 Aug 2024

EPS came in at $0.76 , while revenue for the quarter reached $4.51B .

Earnings released on 11 Apr 2024

EPS came in at $0.76 , while revenue for the quarter reached $3.36B .

Dividend declared on 11 Mar 2024

A dividend of $0.60 per share was announced, adjusted to $0.60. The dividend was paid on 10 Apr 2024.

Earnings released on 13 Feb 2024

EPS came in at $1.95 , while revenue for the quarter reached $4.01B .

Earnings released on 30 Dec 2023

EPS came in at $2.78 , while revenue for the quarter reached $5.69B .

Dividend declared on 15 Aug 2023

A dividend of $0.65 per share was announced, adjusted to $0.65. The dividend was paid on 10 Oct 2023.

Earnings released on 30 Jun 2023

EPS came in at $0.81 , while revenue for the quarter reached $3.93B .

Earnings released on 31 Mar 2023

EPS came in at $0.59 , while revenue for the quarter reached $3.08B .

Dividend declared on 8 Mar 2023

A dividend of $0.54 per share was announced, adjusted to $0.54. The dividend was paid on 11 Apr 2023.

Earnings released on 30 Dec 2022

EPS came in at $2.36 , while revenue for the quarter reached $4.99B .

Earnings released on 30 Sept 2022

EPS came in at $1.70 , while revenue for the quarter reached $3.64B .

Dividend declared on 2 Sept 2022

A dividend of $0.59 per share was announced, adjusted to $0.59. The dividend was paid on 11 Oct 2022.

Earnings released on 30 Jun 2022

EPS came in at $0.67 , while revenue for the quarter reached $2.95B .

Earnings released on 31 Mar 2022

EPS came in at $0.51 , while revenue for the quarter reached $2.27B .

Dividend declared on 17 Feb 2022

A dividend of $0.52 per share was announced, adjusted to $0.52. The dividend was paid on 11 Apr 2022.

Earnings released on 30 Dec 2021

EPS came in at $1.92 , while revenue for the quarter reached $4.32B .

Earnings released on 30 Sept 2021

EPS came in at $1.92 , while revenue for the quarter reached $3.02B .

Dividend declared on 1 Sept 2021

A dividend of $0.59 per share was announced, adjusted to $0.59. The dividend was paid on 5 Oct 2021.

Earnings released on 30 Jun 2021

EPS came in at $0.62 , while revenue for the quarter reached $3.32B .

Earnings released on 31 Mar 2021

EPS came in at $0.62 , while revenue for the quarter reached $2.29B .

Dividend declared on 18 Feb 2021

A dividend of $0.52 per share was announced, adjusted to $0.52. The dividend was paid on 12 Apr 2021.

Earnings released on 30 Dec 2020

EPS came in at $1.97 , while revenue for the quarter reached $2.85B .

Earnings released on 30 Sept 2020

EPS came in at $1.99 , while revenue for the quarter reached $2.87B .

Dividend declared on 19 Aug 2020

A dividend of $0.54 per share was announced, adjusted to $0.54. The dividend was paid on 19 Oct 2020.

CSLLY Stock Performance

Access detailed CSLLY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run